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Abstract: Background: With current Ca and P recommendations for enteral nutrition, preterm infants,
especially VLBW, fail to achieve a bone mineral content (BMC) equivalent to term infants. During
the first 3 years, most notably in light at term equivalent age (<−2 Z score) VLBW infants’ BMC does
not catch up. In adults born preterm with VLBW or SGA, lower adult bone mass, lower peak bone
mass, and higher frequency of osteopenia/osteoporosis have been found, implying an increased risk
for future bone fractures. The aim of the present narrative review was to provide recommendation
for enteral mineral intake for improving bone mineral accretion. Methods: Current preterm infant
mineral recommendations together with fetal and preterm infant physiology of mineral accretion
were reviewed to provide recommendations for improving bone mineral accretion. Results: Current
Ca and P recommendations systematically underestimate the needs, especially for Ca. Conclusion:
Higher enteral fortifier/formula mineral content or individual supplementation is required. Higher
general mineral intake (especially Ca) will most likely improve bone mineralization in preterm infants
and possibly the long-term bone health. However, the nephrocalcinosis risk may increase in infants
with high Ca absorption. Therefore, individual additional enteral Ca and/or P supplementations are
recommended to improve current fortifier/formula mineral intake.
Keywords: preterm infant; bone mineral content; calcium requirements; phosphorus requirements;
bone mineralization
1. Introduction
Appropriate mineral and vitamin D intakes are essential for adequate bone health.
The optimum target for mineral accretion in preterm infants on enteral nutrition is un-
known. The widely accepted physiologically relevant outcome is an accretion of bone mass
that is proportional to the linear growth weight gain as achieved by the fetus in utero and
subsequently the term born infant over the first year [1–5].
1.1. Definition of Bone Mineral Deficiency of Prematurity
Bone mineral deficiency of prematurity (BMDP) defined as insufficient osteoid min-
eralization or reduced bone mineral content [6–8] caused by low or insufficient calcium
and/or phosphate intake has been reviewed recently [9–13]. This condition is commonly
referred to in the literature as “osteoporosis of prematurity”, “rickets of prematurity”,
“osteomalacia of prematurity”, “osteopenia of prematurity”, or “metabolic bone disease
of prematurity”.
1.2. Clinical Signs of BMDP in Preterm Infants
BMDP is associated with a variety of clinical signs, e.g., enamel hypoplasia and
caries [14,15], fractures [16–18], radiological signs of diminished bone mineralization [9],
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myopia and against the rule astigmatism [19], and dolichocephalic head flattening together
with deformation of the palate [20]. Incidences of BMDP of about 40% [9] in very low
birthweight (VLBW) infants and 50% in extremely low birthweight (ELBW) infants [21]
have been reported in the past. Fractures have been observed in about 30% of VLBW
infants [22,23] in the eighties. In ELBW infants from that time, improved nutrition with
enrichment with minerals have reduced the reported incidences of fractures at least down to
7–10% [24,25] and radiological BMDP down to 15% [26]. Even though the actual incidence
of BMDP or fractures is unknown, ELBW infants are especially at risk [24,27]. Whereas
dolichocephalic deformation of the skull is still seen in the clinical experience of the authors,
fracturs are a rare event and only occasionally seen in extremely immature infants. Routine
skeletal X-ray screening is therefore not recommended.
1.3. BMD in the First Years of Life
At term equivalent age, preterm infants grossly fail to meet the whole-body BMC of
infants born at full term [28,29]. At 6 months of age, in a previous study, a similar BMC has
been found in preterm infants as in a previous group of full term infants [28] and a catch-up
of BMD in preterm infants within the first year of life has been hypothesized [30] and
shown in a recent pilot study in which infants received extra mineral intake upon discharge
until deemed appropriate [31]. In contrast, recent meticulously performed longitudinal
data showed lower BMC, lower BMD and lower BMC/length2 in VLBW preterm infants
throughout the first 3 years of life [32]. Particularly light for term equivalent age VLBW
infants appear to be at highest risk.
1.4. BMD at Child Age and in Adults
For child age, conflicting data have been published. One study reports a clear trend
towards a reduced BMD in former preterm infants, but no significant difference was
found [33] whereas others report significantly reduced bone mineral density in former
preterm infants when compared to term infants [34,35]. Previous reviews on bone health
in adults did not indicate a significant effect of birth weight on adult BMC [36]. In the only
available randomized trial, adult peak bone mass was not associated with early mineral
intake [23]. However, “compared with population reference data, preterm subjects were
significantly shorter and had lower lumbar spine bone mineral density; the deficits were
greatest in those born small for gestational age” [23]. Several more recent observational
studies in adults born preterm with VLBW or SGA found lower adult bone mass, lower
peak bone mass (usually achieved by the 3rd decade of life, regarded as the most important
determinant of osteoporosis) and higher frequency of osteopenia/osteoporosis, implying an
increased future fracture risk [37–42]. The most pronounced bone deficits are seen in VLBW
adults, suggesting a role of early life programming in skeletal development [37,39,41,42].
In conclusion, appropriate mineral (and vitamin D) intakes are essential for adequate
bone health. The available data suggest that current enteral recommendations for Ca and P
intake in preterm infants do not meet lifetime needs for all infants.
2. Materials and Methods
The present paper is a narrative review, with main focus: preterm infants in hospital
up to 34 weeks of gestation because discharge programs will start thereafter. A PubMed
search was performed to identify current recommendations for enteral nutrition of preterm
infants published after the year 2000. All enteral recommendations were analyzed for their
individual basis.
The physiology of fetal mineral accretion and preterm infants’ mineral absorption was
reviewed because all enteral recommendations were based on these two pillars.
Finally, conclusions, enteral mineral recommendations, and future research recom-
mendations were derived from the presented data.
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3. Results
3.1. Current Recommendations for Enteral Ca and P Intake in Preterm Infants
Current enteral mineral intake recommendations are given in Table 1 [1–5]. Con-
siderable differences among various experts’ recommendations were found. The lowest
recommendation has been published by ESPGHAN in 2010 [2]. This recommendation is cur-
rently updated. The highest has been published by AAP in 2013 [3]. There is a remarkable
range of recommended intakes of Ca 120–220 mg/kg/day and P 60–140 mg/kg/day. All
recommendations advised to use the same intake for all preterm infants. No individualiza-
tion of the intake has been recommended. There was a consensus in all recommendations
that too low intake of Ca and P is associated with BMDP [1–5]. None of the recommen-
dations provided data on side effects or toxicity of a higher Ca or P intake. None of the
enteral recommendations was based on long term bone health.











Year 2002 2005 2010 2013 2014
Ca mg/kg/day 150–200 120–200 120–140 150–220 120–200
P mg/kg/day 65–90 70–120 60–90 75–140 60–140
3.2. Physiology of Ca and P Requirements
In all enteral recommendations, the estimations of the nutritional mineral requirements
of the preterm infant have been based upon the combination of fetal mineral accretion
combined with the range of mineral absorption rate by the preterm intestine [1–5]. The
fetal mineral accretion during the third trimester was assumed to average mineral accretion
rates of 90–120 mg/kg/day for Ca and 60–75 mg/kg/day for phosphorus [1–5]. However,
estimation of fetal mineral accretion (factorial approach), based on measurements of fetal
body composition and fetal weight gain, may be higher, as outlined below.
3.2.1. Fetal Body Composition
Three major papers on body composition assessment of human fetuses at various
stages of gestation have been published so far [43–45]. Figures 1 and 2 give the calcium and
phosphorus data of all analyzed fetuses in which total body analyses of P and Ca together
have been performed. There is a strong linear association between fetal body weight and
total calcium or total phosphorus measurement. Therefore, with regard to the Ca to P ratio,
fetal body composition is constant throughout the analyzed weight range and absolute
values depend on weight gain.
The data suggest that total body content of Ca and P increase by (8.3 mg) (0.21 mmol
Ca) and 4.7 mg (0.15 mmol P) per gram of body weight. These data have been reconfirmed
e.g., by delayed gamma neutron activation in preterm infants post mortem for Ca and
P [46] and by dual energy x-ray absorptiometry (DXA) in stable term and preterm infants
for Ca [47]. Both of these studies may slightly overestimate the steepness of the slope of the
regression line, because infants were not analyzed right after birth and the smaller preterm
infants are the more rapidly they demineralize after birth [46,47].
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3.2.2. Fetal Weight Gain
Weight gain is obviously the major determinant of mineral requirements. The German
newborn infant’s growth reference was based on the cross-sectional measurement of weight
at birth of more than 1.8 million term and preterm infants, and is therefore regarded as
one of the largest growth references available [48]. Figure 3 shows that there is a highly
significant linear association between gestational age in weeks and the natural logarithms
of the 50th weight percentile of this growth reference. These data suggest that the average
fetal (intrauterine) weight gain of infants up to 34 weeks of gestation may mathematically
be approximated by exponential weight gain of 17 g/kg/day.
On the basis of both cross-sectional BW data (basically the US growth reference by
Alexander et l. [49]) and ltrasound fetal weight data, the recommendation by Klein
concluded that intrauterine fetal weight gai is approximately 16–17 g/kg/day up to
34 weeks GA [5]. More recently, several additional fetal growth f ences have been
analyzed by William Hay [50]. The average weight gain among this diverse population
was 17 g/day/kg, ran i g from 15 to 20 g/day/kg for average sized infants, slower for
smaller infants and faster for larger infants. Therefore, recommendations may reasonably
be based on the average fetal weight gain of 17 g/kg/day up to 34 weeks of gestation.
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rate is 141 mg/kg/day (3.52 mmol/kg/day) for Ca and 80 mg/kg/day (2.58 mmol/kg/da )
for phosphorus. These values are far above the assumptions on with th m jority of rece t
recommendations were based on and provide a more appropriate average reference target.
Approximately 98% of the calcium, 3.45 mmol/kg/day, is used for bone mineralization and
deposited as microcrystalline apatite (Ca5(PO4)3) with a fixed molar Ca/P ratio of 1.67. The
corresponding average phosphorus accretion in apatite is 2.07 mmol/kg/day. The remain-
ing fetal phosphorus accretion is used for tissue accretion (0.5 mmol/kg/day). Average
molar fetal whole-body Ca/P ratio is therefore 1.36. At slower weight gain (15 g/kg/day)
the ideal average mineral accretion would be 125 mg/kg/day (3.1 mmol/kg/day) for
Ca and 71 mg/kg/day (2.28 mmol/kg/day) for phosphorus. Faster target weight gain
(20 g/kg/day) would increase the average mineral accretion target up to 164 mg/kg/day
(4.09 mmol/kg/day) for Ca and 94 mg/kg/day (3.03 mmol/kg/day) for phosphorus.
3.2.3. Ca and P Absorption
Average net intestinal Ca absorption in preterm infants (35–82%) may be slightly
higher with multi-nutrient fortified human milk than with bovine milk based preterm
formulas [1]. However, such observations are not consistent, because a variety of factors
confound Ca absorption such as the source of the mineral salt and the amount and quality
of fat, protein, carbohydrate and phosphorus in the diet [1]. In addition, the individual
variability may be as high as 21% to 90% [1]. Basically, net calcium absorption from sup-
plemented own mother´s milk or banked human milk or from preterm formulas fed to
1-month-old premature infants appears to be a linear function of intake at least in the
range of 40–120 mg of calcium/(kg/day) [51]. In contrast, P absorption in preterm infants
is usually at least 80% (reported range 60–95%) of the intake [1,4]. Therefore, it may be
impossible to cover all individual infant’s needs, all formula and human milk supplement
Ca/P bioavailability with only one given Ca and P concentration. The variations in Ca and
P absorption explain most of the observed differences among various experts’ recommenda-
tions (Table 1). The neonatologist needs to know the Ca and P bioavailability of the various
nutritional products used. This information should be provided by the manufacturers.
In some individual preterm infants, a net Ca and P retention closer to fetal accretion has
been reporte (e.g., see [1]). For instance, in a study providing 222 mg Ca/kg/day, Ca re-
tention was 134 mg/kg/day [52]. However, giv n the average weight gain of 21 g/kg/day
in this study, the achieved average mineral accretion r te was far below fetal mineral
accretion (s e Section 3.2.2.). On av rage, at term equivalent age and at 3 mon hs of cor-
rected ag preterm infa ts still f il to achiev term infant whole-body bone mineral content
(BMC) [28,29,32].
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3.2.4. Individualized Ca and P Supplementation
On the other hand, in individualized Ca and P supplementation (target: provision of
a slight surplus defined by simultaneous urinary excretion of Ca and P in spot urine at low
concentrations of 1–2 mmol/L) average fetal bone mineral accretion has been achieved
and validated by single photon absorptiometry (SPA) and balance studies [53]. In these
studies, considerably higher average Ca (260 mg/kg/day) intakes were required than rec-
ommended, whereas the average P intake (100 mg/kg/day) was within the recommended
range (Table 1) [54]. Individualized enteral Ca/P supplementation has been studied suc-
cessfully using organic Ca (Ca-gluconate) and P (Na2-glycerophosphate) salts (please see
ref. [53,54] for details).
Additional Ca supplementation was required in the vast majority of infants on sup-
plemented human milk feeding or preterm formula feeding. Gastrointestinal disturbances
have not been observed.
3.2.5. Caveats in Individualized Ca and P Supplementation
In individualized mineral supplementation, inorganic Ca or P salts are critical when
used for supplementation or as a formula component. Precipitation of Ca/P salts may
prevent absorption. For instance, dipotassium phosphate as supplement has been shown
to reduce Ca absorption from formula (P source: tribasic calcium phosphate and nonfat
dry milk) in a balance study [52]. In a second study, dipotassium phosphate as a formula
component prevented the absorption of Ca from Ca-gluconate as a supplement, possibly
because precipitation limited the bioavailability of both Ca and inorganic P [55]. On the
other hand, organic Ca and P salts have been used successfully (Ca-gluconate and Na2-
glycerophosphate) [54]. Of note, breast milk phosphates are organically bound to casein
micelles, which may be nature’s solution to prevent precipitation [56]. In some units, Ca
and P supplements are therefore administered at different times of the day to prevent
precipitation. Altogether, supplementation strategies need to be validated [54]. Several
additional tools for monitoring and individualizing the adequacy of Ca and P intake have
been used or recommended, e.g., serum phosphate, serum alkaline phosphatase, PTH,
urinary Ca/Crea and P/Crea quotients, and bone speed of sound. None of them has been
prospectively validated so far by providing a management algorithm.
3.2.6. Risks of High Enteral Mineral Supplementation
Sometimes, nurses reported more loose stools with high enteral Ca-gluconate supple-
mentation [54]. On the other hand, stool hardness is associated with stool Ca-soaps and
therefore each Ca and P supplement or salt has to be analyzed for efficacy, efficiency and
tolerance. Increasing the general Ca and P intake recommendations for all infants may
be beneficial for the whole group of preterm infants with regard to bone mineralization;
however, it may be harmful for the subgroup of infants with high mineral bioavailability.
Urinary excretion of Ca and P may grossly increase in theses infants and increase the
incidence of nephrocalcinosis, which has been estimated to occur in at least 7% in VLBW
infants [57–60]. Especially infants with high Ca reabsorption may be affected. Therefore, in-
dividually adjusted additional supplementation may be safer. Here the target is to archive
a slight Ca and P surplus defined by simultaneous spot urine excretion of both Ca and P at
low concentrations.
In summary, previous recommendations for enteral Ca and P intake fail to meet the
requirements of preterm infants for two reasons: 1. The average intrauterine Ca and
P accretion is systematically underestimated. 2. The average enteral Ca bioavailability
is systematically overestimated. The data suggest that promotion of adequate nutrition
with sufficient minerals and vitamin D, and possibly an increase in weight-bearing exer-
cise [42] are thus important for former VLBW infants till adulthood [39] and support the
hypothesis that improved bone mineralization before discharge may improve lifelong bone
health. In hospital, bone mineral accretion largely depends on enteral intake. Therefore,
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current Ca and P recommendations may be insufficient to meet the needs [2,61]. Higher
fortifier/formula mineral content or individual supplementation may be required [54,62].
4. Conclusions and Recommendations
4.1. Conclusions
1. Ca and P requirements depend on weight gain.
2. Current recommendations for enteral Ca and P intake fail to meet the requirements of
preterm infants for two reasons:
a. Given a target neonatal weight gain above 17 g/kg/day, the average intrauter-
ine Ca and P accretion is systematically underestimated.
b. The average enteral Ca bioavailability is systematically overestimated.
3. Promotion of adequate nutrition with sufficient minerals (and vitamin D) may pro-
mote long-term bone health.
4. Increasing the enteral intake recommendations for all infants (especially Ca intake)
may improve average bone mineralization at the risk of a higher incidence of nephro-
calcinosis.
4.2. Recommendations
1. Individually adjusted additional enteral mineral supplementation to improve current
mineral intake by formula/fortifier should be performed to prevent inadequately low
infant BMC and to reduce the risk of nephrocalcinosis.
2. Organic phosphate salts such as glycerophosphate or glucose phosphate should be
preferred, because inorganic phosphate salts precipitate much more easily, especially
when combined with calcium supplements, thus reducing the bioavailability of both
Ca and P.
3. Local individualized Ca and P supplementation strategies should be validated. This
includes the idea of separating Ca and P supplement administrations to different
times of the day.
4. Future enteral Ca and P recommendation should be based on long-term bone health
as well.
4.3. Research Direction for Future Studies
The current recommendations for enteral Ca and P intake fail to meet the requirements
of preterm infants with regard to long-term bone health. However, it is unclear which
level of mineralization must be achieved in preterm infants for prevention of long-term
bone mineral deficits. Previous data have shown that there is some degree of bone mineral
catch-up in VLBW infants post discharge within the first three years of life [32]. Further
studies need to show which degree of reduced bone mineral content may be tolerated at
discharge compared to term infants.
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